CN1136896C - Live-nourishing 'yanggan' pill - Google Patents
Live-nourishing 'yanggan' pill Download PDFInfo
- Publication number
- CN1136896C CN1136896C CNB011222522A CN01122252A CN1136896C CN 1136896 C CN1136896 C CN 1136896C CN B011222522 A CNB011222522 A CN B011222522A CN 01122252 A CN01122252 A CN 01122252A CN 1136896 C CN1136896 C CN 1136896C
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- treatment
- hepatopathy
- hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
The present invention provides a prescription for treating liver diseases, which comprises licorice, schisandra fruit, chicken gizzard-membrane, ginseng, angelica, oriental wormwood, turtle shell, red sage root, jujubae, isatis leaf, astragalus root and cogongrass rhizome. The present invention has the advantages of extensive applicability, obvious effect, good therapeutic effect, convenient taking, high safety and reliability, simple preparation technology and low cost, and can be used for treating hepatitis A, hepatitis B, hepatitis C, ascites due to cirrhosis, fatty liver, etc. 3000 clinical tests indicate that the effective rate is 90%, the effectual rate is 75%, and the curative rate is 65%.
Description
The present invention relates to medicine, particularly treat the Chinese medicine of hepatopathy.
Hepatopathy is a kind of commonly encountered diseases, because this disease stubbornness, the course of disease are long, causes serious financial burden and mental pressure to patient and family thereof.Particularly hepatitis B is seriously endangering human beings'health especially, affects people's life.At present, human treatment to hepatopathy also is in the exploratory stage, and the medicine kind is many, but or costs an arm and a leg or poor effect.
The object of the present invention is to provide low, the good effect of a kind of price, the Chinese medicine manufacture method of treatment hepatopathy.
The objective of the invention is to realize: a kind of medicine for the treatment of hepatopathy by following scheme, its composition comprises, Radix Glycyrrhizae, Fructus Schisandrae Chinensis, Endothelium Corneum Gigeriae Galli, Radix Ginseng, Radix Angelicae Sinensis, Herba Artemisiae Scopariae, Carapax Trionycis, Radix Salviae Miltiorrhizae, Fructus Jujubae, Folium Isatidis, the Radix Astragali, Rhizoma Imperatae, with Radix Glycyrrhizae heavily is 1, and all the other each components are in regular turn: 2～4,2～6,2～6,3～7,3～7,6～10,6～10,6～10,8～12,8～12,8～12.
During making, more than 12 flavor Chinese medicines oven dry, be ground into fine powder, sieve, making pellets by mixing medical powder with honey, airing gets final product.
The present invention has the following advantages: 1, the suitability is wide, can be used for treatments such as hepatitis A, hepatitis B, hepatitis C, cirrhotic ascites, fatty liver; 2, taking convenience has no side effect, and virus is discharged by urine, and is safe and reliable; 3, instant effect, therapeutic effect is good, shows through 3000 many cases clinical trials, and effective percentage is 90%, and obvious effective rate is 75%, and cure rate is 65%; 4, apolegamy Chinese medicine is few, and processing technology is simple, and cost is lower.
The invention will be further described below in conjunction with embodiment:
Embodiment 1: a kind of medicine for the treatment of hepatopathy, its composition comprises, Radix Glycyrrhizae, Fructus Schisandrae Chinensis, Endothelium Corneum Gigeriae Galli, Radix Ginseng, Radix Angelicae Sinensis, Herba Artemisiae Scopariae, Carapax Trionycis, Radix Salviae Miltiorrhizae, Fructus Jujubae, Folium Isatidis, the Radix Astragali, Rhizoma Imperatae, with Radix Glycyrrhizae heavily is 1, and all the other each components are in regular turn: 2～4,2～6,2～6,3～7,3～7,6～10,6～10,6～10,8～12,8～12,8～12.
During making, more than 12 flavor Chinese medicines oven dry, be ground into fine powder, sieve, making pellets by mixing medical powder with honey, airing gets final product.
Embodiment 2: a kind of medicine for the treatment of hepatopathy, its composition comprises, Radix Glycyrrhizae, Fructus Schisandrae Chinensis, Endothelium Corneum Gigeriae Galli, Radix Ginseng, Radix Angelicae Sinensis, Herba Artemisiae Scopariae, Carapax Trionycis, Radix Salviae Miltiorrhizae, Fructus Jujubae, Folium Isatidis, the Radix Astragali, Rhizoma Imperatae, with Radix Glycyrrhizae heavily is 1, all the other each components are in regular turn: a kind of medicine for the treatment of hepatopathy, its composition comprises, Radix Glycyrrhizae, Fructus Schisandrae Chinensis, Endothelium Corneum Gigeriae Galli, Radix Ginseng, Radix Angelicae Sinensis, Herba Artemisiae Scopariae, Carapax Trionycis, Radix Salviae Miltiorrhizae, Fructus Jujubae, Folium Isatidis, the Radix Astragali, Rhizoma Imperatae, with Radix Glycyrrhizae heavily is 1, and all the other each components are in regular turn: 2.5,3,3,4,4,7,7,7,9,9,9.Manufacture method is with embodiment 1.
Embodiment 3: a kind of medicine for the treatment of hepatopathy, its composition comprises, Radix Glycyrrhizae, Fructus Schisandrae Chinensis, Endothelium Corneum Gigeriae Galli, Radix Ginseng, Radix Angelicae Sinensis, Herba Artemisiae Scopariae, Carapax Trionycis, Radix Salviae Miltiorrhizae, Fructus Jujubae, Folium Isatidis, the Radix Astragali, Rhizoma Imperatae, with Radix Glycyrrhizae heavily is 1, and all the other each components are in regular turn: 2.8,3.5,3.5,4.5,4.5,7.5,7.5,7.5,9.5,9.5,9.5.Manufacture method is with embodiment 1.
Embodiment 4: a kind of medicine for the treatment of hepatopathy, its composition comprises, Radix Glycyrrhizae, Fructus Schisandrae Chinensis, Endothelium Corneum Gigeriae Galli, Radix Ginseng, Radix Angelicae Sinensis, Herba Artemisiae Scopariae, Carapax Trionycis, Radix Salviae Miltiorrhizae, Fructus Jujubae, Folium Isatidis, the Radix Astragali, Rhizoma Imperatae, with Radix Glycyrrhizae heavily is 1, and all the other each components are in regular turn: 3.0,3.6,3.7,4.6,4.7,7.6,7.7,7.8,9.6,9.7,9.8.Manufacture method is with embodiment 1.
Embodiment 5: a kind of medicine for the treatment of hepatopathy, its composition comprises, Radix Glycyrrhizae, Fructus Schisandrae Chinensis, Endothelium Corneum Gigeriae Galli, Radix Ginseng, Radix Angelicae Sinensis, Herba Artemisiae Scopariae, Carapax Trionycis, Radix Salviae Miltiorrhizae, Fructus Jujubae, Folium Isatidis, the Radix Astragali, Rhizoma Imperatae, with Radix Glycyrrhizae heavily is 1, and all the other each components are in regular turn: 3.5,4.3,4.3,5.3,5.3,8.2,8.3,8.4,10.2,10.3,10.4.Manufacture method is with embodiment 1.
Embodiment 6: a kind of medicine for the treatment of hepatopathy, its composition comprises, Radix Glycyrrhizae, Fructus Schisandrae Chinensis, Endothelium Corneum Gigeriae Galli, Radix Ginseng, Radix Angelicae Sinensis, Herba Artemisiae Scopariae, Carapax Trionycis, Radix Salviae Miltiorrhizae, Fructus Jujubae, Folium Isatidis, the Radix Astragali, Rhizoma Imperatae, with Radix Glycyrrhizae heavily is 1, and all the other each components are in regular turn: 3.6,4.5,4.5,5.5,5.5,8.5,8.5,8.5,10.5,10.5,10.5.Manufacture method is with embodiment 1.
Embodiment 7: a kind of medicine for the treatment of hepatopathy, its composition comprises, Radix Glycyrrhizae, Fructus Schisandrae Chinensis, Endothelium Corneum Gigeriae Galli, Radix Ginseng, Radix Angelicae Sinensis, Herba Artemisiae Scopariae, Carapax Trionycis, Radix Salviae Miltiorrhizae, Fructus Jujubae, Folium Isatidis, the Radix Astragali, Rhizoma Imperatae, with Radix Glycyrrhizae heavily is 1, and all the other each components are in regular turn: 3.8,5,5,6,6,9,9,9,11,11,11.Manufacture method is with embodiment 1.
Claims (4)
1, a kind of medicine for the treatment of hepatopathy is characterized in that it is made by the following weight proportion raw material: Radix Glycyrrhizae, Fructus Schisandrae Chinensis, Endothelium Corneum Gigeriae Galli, Radix Ginseng, Radix Angelicae Sinensis, Herba Artemisiae Scopariae, Carapax Trionycis, Radix Salviae Miltiorrhizae, Fructus Jujubae, Folium Isatidis, the Radix Astragali, Rhizoma Imperatae=1: 2～4: 2～6: 2～6: 3～7: 3～7: 6～10: 6～10: 6～10: 8～12: 8～12: 8～12.
2, a kind of medicine for the treatment of hepatopathy according to claim 1 is characterized in that the weight proportion of each raw material is: Radix Glycyrrhizae, Fructus Schisandrae Chinensis, Endothelium Corneum Gigeriae Galli, Radix Ginseng, Radix Angelicae Sinensis, Herba Artemisiae Scopariae, Carapax Trionycis, Radix Salviae Miltiorrhizae, Fructus Jujubae, Folium Isatidis, the Radix Astragali, Rhizoma Imperatae=1: 2.5～3.8: 3～5: 3～5: 4～6: 4～6: 7～9: 7～9: 7～9: 9～11: 9～11: 9～11.
3, a kind of medicine for the treatment of hepatopathy according to claim 1 is characterized in that the weight proportion of each raw material is: Radix Glycyrrhizae, Fructus Schisandrae Chinensis, Endothelium Corneum Gigeriae Galli, Radix Ginseng, Radix Angelicae Sinensis, Herba Artemisiae Scopariae, Carapax Trionycis, Radix Salviae Miltiorrhizae, Fructus Jujubae, Folium Isatidis, the Radix Astragali, Rhizoma Imperatae=1: 2.8～3.6: 3.5～4.5: 3.5～4.5: 4.5～5.5: 4.5～5.5: 7.5～8.5: 7.5～8.5: 7.5～8.5: 9.5～10.5: 9.5～10.5: 9.5～10.5.
4, a kind of medicine for the treatment of hepatopathy according to claim 1 is characterized in that the weight proportion of each raw material is: Radix Glycyrrhizae, Fructus Schisandrae Chinensis, Endothelium Corneum Gigeriae Galli, Radix Ginseng, Radix Angelicae Sinensis, Herba Artemisiae Scopariae, Carapax Trionycis, Radix Salviae Miltiorrhizae, Fructus Jujubae, Folium Isatidis, the Radix Astragali, Rhizoma Imperatae=1: 3.0～3.5: 3.6～4.3: 3.7～4.3: 4.6～5.3: 4.7～5.3: 7.6～8.2: 7.7～8.3: 7.8～8.4: 9.6～10.2: 9.7～10.3: 9.8～10.4.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011222522A CN1136896C (en) | 2001-06-26 | 2001-06-26 | Live-nourishing 'yanggan' pill |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011222522A CN1136896C (en) | 2001-06-26 | 2001-06-26 | Live-nourishing 'yanggan' pill |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1329913A CN1329913A (en) | 2002-01-09 |
| CN1136896C true CN1136896C (en) | 2004-02-04 |
Family
ID=4664669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011222522A Expired - Fee Related CN1136896C (en) | 2001-06-26 | 2001-06-26 | Live-nourishing 'yanggan' pill |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1136896C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106540146A (en) * | 2015-09-23 | 2017-03-29 | 刘从双 | A kind of Chinese patent medicine for treating hepatopathy |
| CN105106909A (en) * | 2015-09-25 | 2015-12-02 | 孙志军 | Traditional Chinese medicine composition for treating hepatitis A |
-
2001
- 2001-06-26 CN CNB011222522A patent/CN1136896C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1329913A (en) | 2002-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1334121A (en) | Medicinal composition for restoring cardiac collaterals and its application | |
| CN1814211A (en) | Chinese herbal medicine decoction for treating acute icterohepatitis and preparing method | |
| CN101653529A (en) | Medicine for treating allergic rhinitis | |
| CN102552454A (en) | Traditional Chinese medicine for curing diabetic foot | |
| CN1150018C (en) | Medicine for treating tachy-arrhythmia | |
| CN101862424B (en) | Chinese medicinal composition for treating hepatitis B and preparation method thereof | |
| CN1931329A (en) | Stomatocase treating medicine | |
| CN1056295C (en) | Chinese medicine prepn for balancing internal secretion | |
| CN1218706C (en) | Hepatitis B treaitng pill | |
| CN105079444A (en) | Traditional Chinese medicine composition for treating bronchial asthma | |
| CN105233017A (en) | Traditional Chinese medicine decoction for treatment of lung-deficiency cough | |
| CN1136896C (en) | Live-nourishing 'yanggan' pill | |
| CN101564505B (en) | Chinese medicament for treating pulmonary heart disease | |
| CN1090183A (en) | Artemisia scoparia and ginseng pellet for mourishing liver and method for production thereof | |
| CN101336998B (en) | Traditional Chinese medicine for treating whelk | |
| CN1101199C (en) | Chinese-medicinal capsule for treating hyperlipomia | |
| CN101843829B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101884731A (en) | Traditional Chinese medicine for treating silicosis | |
| CN1263479C (en) | Chinese traditional medicine for treating cardiopathy | |
| CN100364605C (en) | Specific pellet for treating cold, and preparation method | |
| CN1058395C (en) | Inhalant for prevention and treatment of baldness | |
| CN102125650A (en) | Join shellfish cough and asthma powder | |
| CN101658661A (en) | Chinese medicinal composition having effect of promoting blood circulation and removing blood stasis | |
| CN101897847B (en) | Traditional Chinese medicine for curing asthma | |
| CN101152300A (en) | Traditional Chinese medicine for treating stasis accumulation intestinal obstruction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |